Ultra

Avicanna Reports Full Year 2023 Audited Financial Results 

Retrieved on: 
Tuesday, April 2, 2024
Cream, Cannabidiol, Cannabinoid, Dravet syndrome, Brazilian Health Regulatory Agency, Interest, Medical cannabis, Seizure, Business, Lennox–Gastaut syndrome, Patient, Pharmacy, Active ingredient, Research, Acquisition, RDC, Ultra, Stock, CBD, Insurance, Health Canada, Bank statement, GMP, Dermatology, TSX, Therapy, Pharmaceutical industry

TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce year end 2023 results and audited financial statements.

Key Points: 
  • TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce year end 2023 results and audited financial statements.
  • Cash used in operations of $1.38 million; an 81% reduction compared to $7.4 million in 2022.
  • “2023 was a tremendous year for Avicanna where we solidified of our leadership position in the Canadian medical cannabis sector through our proprietary products and the launch of MyMedi.ca.
  • We have successfully demonstrated the scalability of our revenues and made significant improvements in our fundamentals while advancing all our business pillars.

Metagenomi Reports Business Updates and Full Year 2023 Financial Results

Retrieved on: 
Wednesday, March 27, 2024
Research, Dicarboxylic acid, AAV, Enzyme, Development, Gene editing, CAST, Cardiovascular disease, Haemophilia, Vivisection, Patient, Primate, RNA, DNA, Wave 1, Sale, Metagenomics, G&A, IPO, Ultra, Doctor of Philosophy, Protein, MBA, Genome, SMART, Factor VIII, CRISPR, Amyloidosis, MGX, AGT, Liver, LNP, Ionis, PAM, Vaccine

EMERYVILLE, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived gene editing toolbox, today reported financial results for the full year ended December 31, 2023, and additional business updates.

Key Points: 
  • The aggregate gross proceeds to Metagenomi from the offering were approximately $93.75 million, before deducting underwriting discounts and commissions and offering expenses.
  • In addition, cash used to fund our operations was $91.4 million for the year ended December 31, 2023.
  • R&D Expenses: Research and development (R&D) expenses were $94.4 million for the full year ended December 31, 2023.
  • G&A Expenses: General and administrative (G&A) expenses were $28.8 million for the full year ended December 31, 2023.

AUKEY Launches Two Award-Winning Wireless Charging Stations

Retrieved on: 
Tuesday, March 26, 2024
PR, Apple Watch, Qi, IPhone, MFW, Running, Ultra, Compatibility, IPhone 12, AirPods, Electric battery

Los Angeles, CA, March 26, 2024 (GLOBE NEWSWIRE) -- AUKEY , a leading provider of charging technology, has launched two award-winning Qi2 wireless charging solutions: MagFusion Z and MagFusion 3-in-1.

Key Points: 
  • Los Angeles, CA, March 26, 2024 (GLOBE NEWSWIRE) -- AUKEY , a leading provider of charging technology, has launched two award-winning Qi2 wireless charging solutions: MagFusion Z and MagFusion 3-in-1.
  • In particular, they can charge an iPhone 15 Pro from 0 to 20% in 16 minutes — 65% faster than a standard Qi wireless charger.
  • The chargers are also MFW (Made for Watch) certified, enabling them to deliver fast charging to Apple Watch 7 and later models, including Ultra models.
  • "MagFusion 3-in-1 and MagFusion Z are not just wireless chargers; they’re a revolution in charging convenience," said Lu Haichuan, CEO of AUKEY.

InterDigital to Showcase Innovations in High Definition and Sustainable Video Streaming Alongside Partners at NAB 2024

Retrieved on: 
Tuesday, March 26, 2024
InterDigital, IDCC, NAB, Research, AI, Ultra, Engineering, HDR, Workflow, SDR, Education minister, ATSC 3.0, Nextgen, ATSC, Television

WILMINGTON, Del., March 26, 2024 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, announced plans to showcase their contributions to video streaming and sustainability technologies alongside partners at NAB 2024.

Key Points: 
  • WILMINGTON, Del., March 26, 2024 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, announced plans to showcase their contributions to video streaming and sustainability technologies alongside partners at NAB 2024.
  • At NAB, partners InterDigital and Philips will highlight progress in industry adoption of Advanced HDR solutions that support the bandwidth-efficient distribution of HDR content for any type of video streaming service provider or live broadcast production workflow.
  • At NAB booth W4007, members of the Ultra HD Forum will showcase current and future-looking solutions and strategies that support the sustainable delivery of Ultra HD content.
  • To register and learn more, please visit the NAB 2024 website here .

Saudi Arabia Elevators and Escalators Market Report 2023 and 2024-2029: Increased New Installations Fuelled by Smart City Projects & Investment Across Public Infrastructure - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 9, 2024
Residential Building & Real Estate, Commercial Building & Real Estate, Construction & Property, Building Systems, Jeddah Tower, Fujitec, Najdi, Transport, Elevator, Ultra, USD, National Committee, George Nooks, Education, Mitsubishi Electric, NDF, Pleasure, Vision 2030, Metrology, Tourism, Ministry, Schindler, Public Investment Fund, SME, Amala, Legislation, SASO, Mineral Resources Limited, Red Sea Project, Civil defense, Hitachi, Hajj, Operation, TKE, Growth, ThyssenKrupp, COVID-19, Formula, BRT, Arms industry

The "Saudi Arabia Elevators and Escalators Market - Size & Growth Forecast 2024-2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Saudi Arabia Elevators and Escalators Market - Size & Growth Forecast 2024-2029" report has been added to ResearchAndMarkets.com's offering.
  • The Saudi Arabia elevator and escalator market is expected to grow at a CAGR of 5.61% from 2023-2029.
  • The top four vendors in the Saudi Arabia elevator and escalator market include KONE, Otis, Schindler, and TKE, accounting for 62% of the market share.
  • What is the number of installed bases in the Saudi Arabia elevator and escalator market in 2023?

Intel Unleashes Enterprise AI with Gaudi 3, AI Open Systems Strategy and New Customer Wins

Retrieved on: 
Tuesday, April 9, 2024
Technology, Semiconductor, Software, Networks, Internet, Hardware, Electronic Design Automation, Data Management, Consumer Electronics, Artificial Intelligence, Cloud, UEC, Google Cloud, Bosch, Algorithm, GPU, Face, Ultra, CtrlS, LLM, DataStax, FP16, Xeon, Silicon, SGX, Original equipment manufacturer, Cohesity, H100, Anomaly, Advent International, Vision, Fermentation, TERA, Kx Systems, Memory, RAG, Running, SAP, Cancer, Food, IBM, VMware, Nvidia, Credit, Dell Technologies, SAM, NPU, Red Hat, HPE, Vision transformer, Intel, Motivation, Infosys, Trust, MinIO, Supermicro, CLIP, TEE, BF16, Workflow, Data center, Ecosystem, Multimedia, MariaDB

The Intel Gaudi 3 AI accelerator will power AI systems with up to tens of thousands of accelerators connected through the common standard of Ethernet.

Key Points: 
  • The Intel Gaudi 3 AI accelerator will power AI systems with up to tens of thousands of accelerators connected through the common standard of Ethernet.
  • Intel Gaudi 3 promises 4x more AI compute for BF16 and a 1.5x increase in memory bandwidth over its predecessor.
  • Intel outlined its strategy for open scalable AI systems, including hardware, software, frameworks and tools.
  • In addition to the Intel Gaudi 3 accelerator, Intel provided updates on its next-generation products and services across all segments of enterprise AI.

Tutors International Reveals the Most Popular Educational Curricula for UHNW Families Embracing Global Education

Retrieved on: 
Tuesday, April 9, 2024
AP, University, Learning, Achievement Medal, Cambridge Assessment International Education, International, International Baccalaureate, Education, School, Ageing, Ultra, Social responsibility, Student, UHNW, IB, Curriculum, Social skills, Advanced Placement, Tutoring

OXFORD, England, April 9, 2024 /PRNewswire/ -- The world is more interconnected than ever, and Ultra-High-Net-Worth (UHNW) families are setting their sights on education systems that offer more than just traditional learning.

Key Points: 
  • UHNW families often prioritise education curricula that offer flexibility, high academic standards, and global recognition.
  • International General Certificate of Secondary Education (IGCSE): The IGCSE is a globally recognised qualification offered by Cambridge Assessment International Education and other examination boards.
  • Recognising the limitations of traditional schooling in meeting the dynamic needs of UHNW families, Tutors International provides a flexible alternative through private home tutoring.
  • With a network of highly qualified private tutors, Tutors International ensures a seamless educational experience that is both academically rigorous and globally oriented.

Tutors International Reveals the Most Popular Educational Curricula for UHNW Families Embracing Global Education

Retrieved on: 
Tuesday, April 9, 2024
AP, University, Learning, Achievement Medal, Cambridge Assessment International Education, International, International Baccalaureate, Education, School, Ageing, Ultra, Social responsibility, Student, UHNW, IB, Curriculum, Social skills, Advanced Placement, Tutoring

OXFORD, England, April 9, 2024 /PRNewswire/ -- The world is more interconnected than ever, and Ultra-High-Net-Worth (UHNW) families are setting their sights on education systems that offer more than just traditional learning.

Key Points: 
  • UHNW families often prioritise education curricula that offer flexibility, high academic standards, and global recognition.
  • International General Certificate of Secondary Education (IGCSE): The IGCSE is a globally recognised qualification offered by Cambridge Assessment International Education and other examination boards.
  • Recognising the limitations of traditional schooling in meeting the dynamic needs of UHNW families, Tutors International provides a flexible alternative through private home tutoring.
  • With a network of highly qualified private tutors, Tutors International ensures a seamless educational experience that is both academically rigorous and globally oriented.

Deloitte Expands Strategic Alliance With Intel to Help Enterprises Optimize Artificial Intelligence and Generative AI Capabilities

Retrieved on: 
Tuesday, April 9, 2024
Intel, Synthetic media, PC, Digital, Library, AI, Software, Ultra, TCO, Deep learning, Architecture, Graphics processing unit, Data center, Workload, Machine learning, Generative, Medical device

NEW YORK, April 9, 2024 /PRNewswire/ -- Deloitte and Intel announced today a major expansion of their alliance to help enterprises around the world deploy their AI solutions cost efficiently with the latest hardware and software optimizations. These new offerings aim to address the growing needs as the marketplace evolves from experimenting with AI to scaling implementations for distinct use cases that deliver real value. This collaboration can help clients meet and exceed their performance requirements and budget targets by shifting AI workloads to a more cost-efficient architecture.             

Key Points: 
  • This collaboration can help clients meet and exceed their performance requirements and budget targets by shifting AI workloads to a more cost-efficient architecture.
  • Intel and Deloitte have teamed to help clients optimize for their specific industry, workload and situation.
  • Current joint Deloitte and Intel AI offerings include:
    Digital AI Strategy: Analyze and demonstrate the advantages of using Intel-based AI technologies.
  • AI Storefront Solutions: Access Deloitte and Intel-vetted independent software vendors solutions built on next-gen AI hardware and personal computers.

STEALTH BIOTHERAPEUTICS ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR ELAMIPRETIDE FOR THE TREATMENT OF BARTH SYNDROME

Retrieved on: 
Monday, April 8, 2024
Friends, New Drug Application, Elamipretide, Patient, Barth syndrome, NDA, Syndrome, Ultra, Quality of life, Safety, Muscle weakness, Stealth, Fatigue, FDA, Food, Medicine, Pharmaceutical industry

NEEDHAM, Mass., April 8, 2024 /PRNewswire/ -- Stealth BioTherapeutics, a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that the U.S. Food and Drug Administration ("FDA") has accepted for filing its New Drug Application ("NDA") for elamipretide for the treatment of Barth syndrome. The NDA is supported by the positive data from the SPIBA-001 Phase 3 Natural History Control Study and additional supporting efficacy and safety data from the TAZPOWER Part 2 baseline-controlled trial. Elamipretide received Fast Track Designation in 2017, Orphan Drug Designation in 2018 and Rare Pediatric Disease Designation in 2020. 

Key Points: 
  • Elamipretide received Fast Track Designation in 2017, Orphan Drug Designation in 2018 and Rare Pediatric Disease Designation in 2020.
  • The FDA indicated that it is currently planning to hold an advisory committee meeting to discuss the application.
  • The application was assigned a standard review designation, which the Company has asked FDA to reconsider.
  • Elamipretide is also in development for primary mitochondrial myopathy, with pivotal data from the fully-enrolled Phase 3 NuPOWER trial expected in late 2024.